Article

What Role Does Physical Activity Play in the Management of Arthritis?

(AUDIO) That's the question we put to Dr. Leigh Callahan, and in the next 10 minutes, she will address this important issue. Dr. Callahan has over 20 years of experience in arthritis and health outcomes research, and she was an arthritis epidemiologist at the CDC.

That's the question we put to Dr. Leigh Callahan, and in the next 10 minutes, she will address this important issue. Dr. Callahan has over 20 years of experience in arthritis and health outcomes research, and she was an arthritis epidemiologist at the CDC. She is associate professor in the departments of medicine and social medicine and adjunct associate professor in the department of epidemiology at the University of North Carolina at Chapel Hill. She is also director of methology at the Thurston Arthritis Research Center, also in Chapel Hill.

What Role Does Physical Activity Play in the Management of Arthritis?

List of Evidence-Based Programs:CDC Arthritis ProgramCDC Division of Nutrition, Physical Activity and Obesity – Physical Activity for EveryoneNational Institute of Aging –Your Every Day Guide to Exercise and Physical ActivityAmerican College of Rheumatology – Exercise and Arthritis Arthritis Foundation – Introduction to ExerciseArthritis Foundation and Ad Council CampaignLet’s Move Together – Arthritis FoundationLet’s Move Together – Arthritis Foundation (video)American College of Sports Medicine American Council on ExerciseYMCA Active Living Every Day (ALED) (featured courses)Arthritis Foundation Aquatics Program (AFAP) Arthritis Foundation Exercise Program (AFEP)Walk with Ease (WWE) (Group Led)EnhanceFitness (EF)Fit and Strong

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Related Content
Jean-Yves Reginster, MD, PhD, Outstanding Professor of Epidemiology, Public Health and Health Economics, and Professor of Bioethics and Societal Medicine, and Honorary Chair of the Bone and Cartilage Metabolism Unit, at the University of Liège
December 3rd 2024

Denosumab Biosimilar Demonstrates Equivalent Efficacy, Safety in Phase 3 Trial

Victoria Johnson
Emerging Agents in the Treatment of Rheumatic Diseases
October 2nd 2023

Emerging Agents in the Treatment of Rheumatic Diseases

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR Philip J. Mease, MD
FDA Approves Ustekinumab (STELARA) Biosimilar for Crohn’s, UC, Psoriasis, PsA
December 2nd 2024

FDA Approves Ustekinumab (STELARA) Biosimilar for Crohn’s, UC, Psoriasis, PsA

Victoria Johnson
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
August 31st 2023

Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR John B. Boone, MD, FACR Madelaine Feldman MD, FACR
PEGylated Uricase Well-Tolerated, Demonstrates Dose-Dependent Urate-Lowering
November 28th 2024

PEGylated Uricase Well-Tolerated, Demonstrates Dose-Dependent Urate-Lowering

Victoria Johnson
Zahi Touma, MD, PhD, director, Toronto Lupus Program and Associate Professor of medicine, department of medicine, division of rheumatology, Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto
November 27th 2024

Anifrolumab Delayed Onset of Organ Damage in Patients With SLE

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.